Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05465239 · ClinicalTrials.gov registry record · NA

Intelligent and Adaptive Control Applied to Powered Walkers

A NA study, sponsored by Barron Associates.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT05465239 is a NA study that has completed, run by Barron Associates. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05465239, a NA study, has completed, sponsored by Barron Associates.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

The research is towards an advanced control and computer learning strategy that will intelligently drive a powered walker for people with walking disabilities. The aim of the control strategy is to provide powered assistance that optimally reduces the metabolic cost of walking. The goal of the proposed intelligent walker is to reduce the workload of walking, keeping this population walking longer, providing critical exercise, continued muscle development and improved quality of life.

Interventions

  • DEVICE SurePace Powered Walker User

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2020-12-01
Est. Completion 2023-09-30
Phase NA

Sponsor

Barron Associates

10 total trials

What the Registry Record Tells You About NCT05465239

The ClinicalTrials.gov registry entry for NCT05465239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barron Associates, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SurePace Powered Walker User is the first listed.

NCT05465239 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05465239 about?

NCT05465239 is a clinical study titled "Intelligent and Adaptive Control Applied to Powered Walkers". The research is towards an advanced control and computer learning strategy that will intelligently drive a powered walker for people with walking disabilities. The aim of the control strategy is to provide powered assistance that optimally reduces the metabolic cost of walking. The goal of the propo...

What is the current status of trial NCT05465239?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2020-12-01. Estimated completion is 2023-09-30.

What interventions are being tested in trial NCT05465239?

The interventions under investigation include: SurePace Powered Walker User (DEVICE).

Who is sponsoring clinical trial NCT05465239?

This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.